Last reviewed · How we verify

NCT04275609

The Efficiency of Writing Endoscopic Reports by Artificial Intelligence and Physicians: a Randomized Controlled Trial

Status unknown NA Last updated 19 February 2020
What this trial tests

NA trial testing AI generated report in Gastrointestinal Disease in 80 participants. Status unknown.

Timeline
20 February 2020
Primary endpoint
20 March 2020
30 March 2020

Quick facts

Lead sponsorShandong University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment80
Start date20 February 2020
Primary completion20 March 2020
Estimated completion30 March 2020

Drugs / interventions tested

Conditions studied

Sponsor

Shandong University

Who can join

Adults 18 to 80, any sex, with Gastrointestinal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the efficiency of writing endoscopic reports by artificial intelligence and physicians through a randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastrointestinal Disease

Currently open trials in the same condition.

Other Shandong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04275609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing